Qube Research & Technologies (QRT)’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-437,804
Closed -$8.69M 3215
2023
Q1
$8.69M Buy
437,804
+421,755
+2,628% +$7.28M 0.04% 513
2022
Q4
$219K Buy
+16,049
New +$223K ﹤0.01% 1775
2022
Q3
Sell
-52,608
Closed -$755K 3212
2022
Q2
$755K Buy
+52,608
New +$913K 0.01% 1222
2022
Q1
Sell
-42,035
Closed -$789K 3196
2021
Q4
$789K Buy
+42,035
New +$1.12M 0.01% 1327
2021
Q2
Sell
-6,648
Closed -$255K 2953
2021
Q1
$255K Buy
+6,648
New +$283K ﹤0.01% 1541
2020
Q3
Sell
-8,699
Closed -$274K 2216
2020
Q2
$274K Buy
8,699
+2,806
+48% +$105K ﹤0.01% 1341
2020
Q1
$207K Buy
5,893
+968
+20% +$40.8K 0.01% 862
2019
Q4
$239K Buy
+4,925
New +$224K 0.01% 1322

Other funds holding CSII

Qube Research & Technologies (QRT)'s CSII Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 437,804 shares — an estimated $8.69M sold.

Qube Research & Technologies (QRT) first reported a position in CSII in Q4 2019 and held it in 8 quarters. The position peaked at $8.69M in Q1 2023. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 437,804 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $8.69M.
  • Qube Research & Technologies (QRT) first reported a position in Cardiovascular Systems, Inc. in Q4 2019 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Cardiovascular Systems, Inc. position peaked at $8.69M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.